ArticleCancer management and research2025

Overall Survival of Patients with Metastatic Renal Cell Carcinoma Following the Introduction of Targeted and Immunotherapies: A Norwegian Retrospective, Real-World Registry Data Study (RECON3).

Katarina Puco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.